Product information
From Health Canada
Current status:
Cancelled Pre Market
Current status date:
2017-08-25
Original market date: See footnote 1
Product name:
GABAPENTIN
DIN:
02238673 Electronic product monograph is not available
Company:
OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.
2200 Eglinton Avenue, East
Scarborough
Ontario
Canada
M1L 2N3
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:12.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
N02BF01 GABAPENTIN
Active ingredient group (AIG) number:See footnote5
0125929002
Active ingredient(s) | Strength |
---|---|
GABAPENTIN | 400 MG / CAP |